-H E Skipper Researcher Activity Profile

Research Author Detailed Information 

H E Skipper Publication Rate By Year

H E Skipper has published 13 paper(s) in 1949, 1 paper(s) in 1957, 1 paper(s) in 1960, 4 paper(s) in 1962, 2 paper(s) in 1963, 1 paper(s) in 1964, 5 paper(s) in 1965, 2 paper(s) in 1966, 2 paper(s) in 1967, 1 paper(s) in 1968, 1 paper(s) in 1969, 2 paper(s) in 1970, 2 paper(s) in 1972, 1 paper(s) in 1973, 1 paper(s) in 1986, for a total of 39 research publications in total.

H E He Skipper Author Information

LAST NAME: skipper

FIRST NAME: H E

INITIALS: he

AFFILIATION:

Papers

H E Skipper's Publication Record

1. Carbamates in the chemotherapy of leucemia; the distribution of radioactivity in tissues of mice following injection of carbonyl-labeled urethane. Year Published: 1949
2. Carbamates in the chemotherapy of leukemia; the influence of urethan and blood acid-base equilibrium on mouse chloroleukemia 1394. Year Published: 1949
3. Carbamates in the chemotherapy of leukemia; observation of a possible antileukemic synergism between urethane and methyl-bis (beta-chloroethyl) amine. Year Published: 1949
4. Studies on the hazard involved in use of C14; retention of carbon from labeled sodium bicarbonate. Year Published: 1949
5. Carbamates in the chemotherapy of leukemia; the relationship between chemical structure and anti-leukemic action of a series of urethan derivatives. Year Published: 1949
6. Carbamates in the chemotherapy of leucemia; the distribution of radioactivity in tissues of mice following injection of carbonyl-labeled urethane. Year Published: 1949
7. Carbamates in the chemotherapy of leukemia; the influence of urethan and blood acid-base equilibrium on mouse chloroleukemia 1394. Year Published: 1949
8. Carbamates in the chemotherapy of leukemia; observation of a possible antileukemic synergism between urethane and methyl-bis (beta-chloroethyl) amine. Year Published: 1949
9. Carbamates in the chemotherapy of leukemia; the relationship between chemical structure and anti-leukemic action of a series of urethan derivatives. Year Published: 1949
10. Carbamates in the chemotherapy of leucemia; the distribution of radioactivity in tissues of mice following injection of carbonyl-labeled urethane. Year Published: 1949
11. Carbamates in the chemotherapy of leukemia; the influence of urethan and blood acid-base equilibrium on mouse chloroleukemia 1394. Year Published: 1949
12. Carbamates in the chemotherapy of leukemia; observation of a possible antileukemic synergism between urethane and methyl-bis (beta-chloroethyl) amine. Year Published: 1949
13. Carbamates in the chemotherapy of leukemia; the relationship between chemical structure and anti-leukemic action of a series of urethan derivatives. Year Published: 1949
14. The inhibition of growth of sarcoma 180 by combinations of B6-antagonists and acid hydrazides. Year Published: 1957
15. Experimental adjuvant chemotherapy: an overview. Year Published: 1986
16. Experimental evaluation of potential anticancer agents. XVI. Basic study of effects of certain anticancer agents on kinetic behavior of model bacterial cell populations. Year Published: 1965
17. Experimental evaluation of potenital anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. Year Published: 1965
18. Experimental evaluation of potential anticancer agents. 28. Effects of therapy on viability and rate of proliferation of leukemic cells in various anatomic sites. Year Published: 1965
19. Experimental evaluation of potential anticancer agents. XIX. Sensitivity of nondividing leukemic cell populations to certain classes of drugs in vivo. Year Published: 1965
20. Experimental evaluation of potential anticancer agents. XX. Development of immunity to leukemia L1210 in BDF mice and effects of therapy. Year Published: 1966
21. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Year Published: 1966
22. Chemotherapy of leukemia L1210 by 6-mercaptopurine (NSC-755) in combination with 6-methylthiopurine ribonucleoside (NSC-40774). Year Published: 1967
23. Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Year Published: 1967
24. Success and failure in the treatment of solid tumors. I. Effects of cyclophosphamide (NSC-26271) on primary and metastatic plasmacytoma in the hamster. Year Published: 1968
25. Success and failure in the treatment of solid tumors. II. Kinetic parameters and "cell cure" of moderately advanced carcinoma 755. Year Published: 1969
26. Spontaneous AK leukemia (lymphoma) as a model system. Year Published: 1970
27. Response to therapy of spontaneous, first passage, and long passage lines of AK leukemia. Year Published: 1970
28. The "sensitivity" of resting and dividing cells. Year Published: 1972
29. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules. Year Published: 1972
30. A quick reference chart on cross resistance between anticancer patients. Year Published: 1973
31. Experimental evaluation of potential anticancer agents. VII. Cross resistance of alkylating agent-resistant neoplasms. Year Published: 1962
32. A manual on quantitative drug evaluation in experimental tumor systems. I. Background, description of criteria, and presentation of quantitative therapeutic data on various classes of drugs obtained in diverse experimental tumor systems. Year Published: 1962
33. Drug evaluation in experimental tumor systems: potential and limitations in 1961. Year Published: 1962
34. Experimental clinical cancer chemotherapy. Philosophy at the preclinical level. Year Published: 1962
35. Experimental evaluation of potential anticancer agents. X. A specificity test for distinguishing false positives. Year Published: 1963
36. Experimental evaluation of potential anticancer agents. XI. Quantitative response of the Sa180 system to deoxypyridoxine. Year Published: 1963
37. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIII. ON THE CRITERIA AND KINETICS ASSOCIATED WITH "CURABILITY" OF EXPERIMENTAL LEUKEMIA. Year Published: 1964
38. EXPERIMENTAL EVALUATION OF POTENTIAL ANTICANCER AGENTS. XIV. FURTHER STUDY OF CERTAIN BASIC CONCEPTS UNDERLYING CHEMOTHERAPY OF LEUKEMIA. Year Published: 1965
39. Observations of the retiring chairman of the Cancer Chemotherapy Review Board. Year Published: 1960